Klivira
Request demo

Streamlining Medicare Tysabri Prior Authorization

Navigating Medicare Tysabri prior authorization requirements demands precision, particularly given the varying rules across Original Medicare and Medicare Advantage plans. Klivira automates the submission process, ensuring compliance with payer-specific guidelines.

For clinics and health systems managing patients prescribed Tysabri (natalizumab), understanding the nuances of Medicare prior authorization is critical for revenue cycle integrity. This biological therapy, often administered via infusion, necessitates careful attention to coverage criteria, whether under Original Medicare (Parts A/B) or a Medicare Advantage (Part C) plan. Klivira provides the platform to streamline these complex workflows, reducing administrative burden and accelerating patient access.

Tysabri Coverage Under Medicare: Part B Considerations

Tysabri (natalizumab) is a monoclonal antibody indicated for relapsing forms of multiple sclerosis and Crohn's disease. As an intravenously administered medication, Tysabri typically falls under Medicare Part B (medical benefit) for both the drug and its administration. While Original Medicare's prior authorization scope for Part B services is generally limited, specific scenarios or Medicare Advantage plans may mandate prior authorization for Tysabri to ensure medical necessity and appropriate utilization.

Navigating Medicare Prior Authorization Channels for Tysabri

For Original Medicare (Fee-for-Service) beneficiaries, where prior authorization for Tysabri is required, submissions route through the responsible Medicare Administrative Contractor (MAC) for the provider's jurisdiction. MACs such as Noridian, NGS, WPS, Palmetto, FCSO, and Novitas manage these processes. Medicare Advantage (MA) plans, however, are operated by private insurers and often have broader prior authorization requirements and their own submission portals and criteria, which Klivira's platform is designed to manage.

Key Policy Frameworks: NCDs and LCDs

Medicare coverage for Tysabri is guided by National Coverage Determinations (NCDs) published by CMS, and Local Coverage Determinations (LCDs) issued by the specific MAC for each jurisdiction. These policies outline the medical necessity criteria, indications, and patient selection guidelines that must be met for Tysabri to be covered. Klivira's system integrates NCD and LCD logic, helping to ensure that prior authorization requests align with current policy standards before submission.

Klivira's Approach to Medicare Tysabri PA Automation

Klivira provides a robust solution for managing Medicare Tysabri prior authorization. Our platform offers MAC-aware routing, directing requests to the correct contractor based on jurisdiction. For Medicare Advantage plans, Klivira connects to various payer portals, automating data submission and status tracking. This comprehensive approach minimizes manual effort, reduces submission errors, and accelerates the prior authorization lifecycle for Tysabri.

Considerations for Medicare Advantage Plans

Unlike Original Medicare, Medicare Advantage plans often have more extensive prior authorization requirements and may incorporate formulary tiers, step therapy protocols, or quantity limits for specialty drugs like Tysabri. While CMS-0057-F primarily impacts MA plans by standardizing certain aspects of the prior authorization process, specific plan details remain critical. Klivira's system adapts to these variations, helping providers meet the unique demands of each MA plan's requirements for Tysabri.

Frequently asked questions

Is Tysabri prior authorization always required for Medicare beneficiaries?

Prior authorization requirements for Tysabri vary. For Original Medicare (Part B), PA is less common but can be required in specific circumstances. Medicare Advantage plans, however, frequently mandate prior authorization for specialty drugs like Tysabri, with criteria varying by plan. Klivira helps identify and manage these diverse requirements.

Which Medicare parts cover Tysabri?

Tysabri, as an intravenously administered medication, is typically covered under Medicare Part B (medical benefit) for both the drug and its administration when provided in an outpatient setting. Medicare Advantage plans (Part C) encompass Part A and B benefits and may include Part D, with coverage details depending on the specific plan's design.

How does Klivira handle prior authorizations for Original Medicare Tysabri?

For Original Medicare members, Klivira routes Tysabri prior authorization requests through the appropriate Medicare Administrative Contractor (MAC) based on the provider's jurisdiction. Our system incorporates NCD and LCD policy logic to ensure submissions align with federal and local coverage criteria, streamlining the process where PA is applicable.

What are NCDs and LCDs in the context of Tysabri PA?

National Coverage Determinations (NCDs) are national policies published by CMS that specify Medicare coverage for certain services and drugs. Local Coverage Determinations (LCDs) are policies issued by individual MACs that provide more specific coverage guidelines within their jurisdiction. Both are crucial for determining Tysabri coverage and prior authorization requirements under Medicare.

Are specific MACs involved in Tysabri prior authorization?

Yes, for Original Medicare, prior authorization requests for Tysabri (where required) are handled by the Medicare Administrative Contractor (MAC) responsible for the provider's geographic area. Examples include Noridian, NGS, WPS, Palmetto, FCSO, and Novitas. Klivira's platform intelligently routes submissions to the correct MAC for efficient processing.

Related coverage

Other tysabri prior authorization by payer

Other tysabri prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo